Clinical Trials Browser

Expanded_access × Neurofibroma, Plexiform × Clear all

NCT05028166 2024-03-15

Individual Patient Compassionate Use of Mirdametinib

Neurofibromatoses, Neurofibroma, Plexiform

NCT03259633 2020-05-01

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Approved for marketing

Neurofibroma, Plexiform